Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma patients.

[1]  R. Gorlick,et al.  New targets and approaches in osteosarcoma. , 2013, Pharmacology & therapeutics.

[2]  V. Korshunov.  Axl-dependent signalling: a clinical update. , 2012, Clinical science.

[3]  B. Bauvois,et al.  New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. , 2012, Biochimica et biophysica acta.

[4]  D. Bearss,et al.  Targeting Axl and Mer Kinases in Cancer , 2011, Molecular Cancer Therapeutics.

[5]  J. Fletcher,et al.  AXL regulates mesothelioma proliferation and invasiveness , 2011, Oncogene.

[6]  Douglas B. Evans,et al.  Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma , 2011, Cancer.

[7]  A. Storey,et al.  Axl promotes cutaneous squamous cell carcinoma survival through negative regulation of pro-apoptotic Bcl-2 family members. , 2011, The Journal of investigative dermatology.

[8]  Guang Yang,et al.  Differential expression of Axl in hepatocellular carcinoma and correlation with tumor lymphatic metastasis , 2010, Molecular carcinogenesis.

[9]  Kevin Wei,et al.  AXL is an essential factor and therapeutic target for metastatic ovarian cancer. , 2010, Cancer research.

[10]  M. Hung,et al.  Nuclear Translocation of the Epidermal Growth Factor Receptor Family Membrane Tyrosine Kinase Receptors , 2009, Clinical Cancer Research.

[11]  K. Tai,et al.  Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1 , 2008, Oncogene.

[12]  H. Earp,et al.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. , 2008, Advances in cancer research.

[13]  A. Gilmore,et al.  Axl/Phosphatidylinositol 3-Kinase Signaling Inhibits Mineral Deposition by Vascular Smooth Muscle Cells , 2007, Circulation research.

[14]  S. Chiou,et al.  Overexpression of NBS1 induces epithelial–mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer , 2007, Oncogene.

[15]  H. Seno,et al.  Growth arrest‐specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway , 2007, Molecular carcinogenesis.

[16]  B. Dahlbäck,et al.  Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases. , 2006, Cytokine & growth factor reviews.

[17]  Y. Chu,et al.  Expression of axl in lung adenocarcinoma and correlation with tumor progression. , 2005, Neoplasia.

[18]  J. Yokota,et al.  Biological properties and gene expression associated with metastatic potential of human osteosarcoma , 2004, Clinical & Experimental Metastasis.

[19]  C. J. Chen,et al.  KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. , 2001, Cancer research.

[20]  T. Jacks,et al.  The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. , 2001, Developmental cell.

[21]  C. Messa.  Epidermal Growth Factor and 17ß-Estradiol Effects on Proliferation of a Human Gastric Cancer Cell Line (AGS) , 2000, Scandinavian journal of gastroenterology.

[22]  Pamela F. Jones,et al.  The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases , 1995, Cell.

[23]  R. Espinosa,et al.  axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase , 1991, Molecular and cellular biology.